Difference between revisions of "Phosphaturic mesenchymal tumour, mixed connective tissue type"
Jump to navigation
Jump to search
| Line 8: | Line 8: | ||
| LMDDx = | | LMDDx = | ||
| Stains = | | Stains = | ||
| IHC = vimentin +ve | | IHC = vimentin +ve, pankeratin -ve, S-100 -ve | ||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
| Line 57: | Line 57: | ||
*S-100 -ve. | *S-100 -ve. | ||
*CD34 -ve. | *CD34 -ve. | ||
Others:<ref name=pmid22035861>{{cite journal |author=Hu FK, Yuan F, Jiang CY, ''et al.'' |title=Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature |journal=Chin J Cancer |volume=30 |issue=11 |pages=794–804 |year=2011 |month=November |pmid=22035861 |pmc=4013303 |doi=10.5732/cjc.011.10013 |url=}}</ref> | |||
*CD68 +ve.(???) | |||
*Desmin -ve. | |||
==References== | ==References== | ||
Revision as of 17:52, 6 June 2014
| Phosphaturic mesenchymal tumour, mixed connective tissue type | |
|---|---|
| Diagnosis in short | |
|
| |
| LM | spindle cells without atypia |
| IHC | vimentin +ve, pankeratin -ve, S-100 -ve |
| Site | soft tissue, bone |
|
| |
| Blood work | low serum phosphate |
| Clin. DDx | autosomal dominant hypophosphatemic rickets |
Phosphaturic mesenchymal tumour, mixed connective tissue type, abbreviated PMTMCT, is a rare tumour.
General
- Extremely rare.
- Hypophosphatemia.[1]
- Most common cause of oncogenic osteomalacia (tumour-induced osteomalacia).[2]
Clinical DDx:
- Autosomal dominant hypophosphatemic rickets.[3]
Gross
Microscopic
- Spindle cells without atypia in an eosinophilic matrix.
- Osteoclast-type giant cells.
- +/-Calcifications.
Image:
IHC
Features:[3]
- Vimentin +ve.
- Pankeratin -ve.
- S-100 -ve.
- CD34 -ve.
Others:[6]
- CD68 +ve.(???)
- Desmin -ve.
References
- ↑ Papierska, L.; Ćwikła, JB.; Misiorowski, W.; Rabijewski, M.; Sikora, K.; Wanyura, H. (2013). "Unusual case of phosphaturic mesenchymal tumor.". Pol Arch Med Wewn 123 (5): 255-6. PMID 23722193.
- ↑ 2.0 2.1 William, J.; Laskin, W.; Nayar, R.; De Frias, D. (Aug 2012). "Diagnosis of phosphaturic mesenchymal tumor (mixed connective tissue type) by cytopathology.". Diagn Cytopathol 40 Suppl 2: E109-13. doi:10.1002/dc.21647. PMID 22927293.
- ↑ 3.0 3.1 3.2 3.3 Woo, VL.; Landesberg, R.; Imel, EA.; Singer, SR.; Folpe, AL.; Econs, MJ.; Kim, T.; Harik, LR. et al. (Dec 2009). "Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.". Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 (6): 925-32. doi:10.1016/j.tripleo.2009.07.005. PMC 2783479. PMID 19828339. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783479/.
- ↑ Jiang, Y.; Xia, WB.; Xing, XP.; Silva, BC.; Li, M.; Wang, O.; Zhang, HB.; Li, F. et al. (Sep 2012). "Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.". J Bone Miner Res 27 (9): 1967-75. doi:10.1002/jbmr.1642. PMID 22532501.
- ↑ Ledford, CK.; Zelenski, NA.; Cardona, DM.; Brigman, BE.; Eward, WC. (Jul 2013). "The Phosphaturic Mesenchymal Tumor: Why is Definitive Diagnosis and Curative Surgery Often Delayed?". Clin Orthop Relat Res. doi:10.1007/s11999-013-3178-1. PMID 23868423.
- ↑ Hu FK, Yuan F, Jiang CY, et al. (November 2011). "Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature". Chin J Cancer 30 (11): 794–804. doi:10.5732/cjc.011.10013. PMC 4013303. PMID 22035861. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013303/.